- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02964000
Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis
Adjunct Use of the Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid-containing Medication on a PRN Basis
Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications.
Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Previous studies with low level laser therapy have reported beneficial effects on the level of pain in patients with a variety of chronic pain conditions.
We designed this controlled, double blind, randomized study to determine in the active laser group would have a reduction in the need for 'PRN pain medication'.
Screening Testing
- Urine-toxicology screen.
- Assessment of level of activity and range of motion and functional capacity evaluation for upper and/ or lower extremity.
- Current drug history and use of analgesic medications including both opioid and or non-opioid analgesic medications.
- Drug history and current medications along with non-traditional alternative treatments such as (e.g. acupuncture, massage, herbal treatments, etc.)
Protocol Outline After obtaining written informed consent, patients will be asked to complete all the pre-screening and "entry" questionnaires (e.g., SF-36).
11- point Verbal Rating Scale (VRS) for pain at rest and with physical activity (0= none to 10= severe), level of physical activity (0=inactive to 10= fully active), and quality of sleep (0=poor to 10=excellent).
Current analgesic [pain] medications both daily and PRN medications. Randomized into active (Phoenix Thera-Lase [ PTL]) or "Low level" PTL group using a computer generated random numbers table.
Treatment Sessions After obtaining written informed consent for participating in the study and signing the standard HIPPA forms, the patient will be asked to describe the location of their current pain symptoms.
Pre-treatment baseline assessments VRS for pain at rest and with physical activity (e.g. walking, climbing stairs) Kinesiology functional capacity evaluation (FCE) for upper and/ or lower extremities or low back (depending on location of pain).
Current opioid and non-opioid analgesic medication usage Clinical opioid withdrawal scale (COWS) at baseline (the COWS will be repeated at the end of the 1st, 2nd, and 3rd week of treatments).
Treatment sessions - Active or low level therapy for 20 - 40 min on Monday, Wednesday, and Friday for 3 weeks.
Post- treatment sessions VRS for pain at rest and with ambulation immediately after each treatment
After the end of 3-week treatment period Repeat pre-screening questionnaires. Kinesiology functional capacity evaluation (FCE) for upper and/ or lower extremities or low back (depending on location of pain).
Long-term Follow Up 30-days after the last treatment session, a standardized follow-up questionnaire will be administered.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Paul F White, PhD, MD
- Telefonnummer: 214-770-3775
- E-mail: paul.white@cshs.org
Undersøgelse Kontakt Backup
- Navn: Ofelia Loani Elvir Lazo, MD
- Telefonnummer: 310-721-0590
- E-mail: loanidoc@yahoo.com
Studiesteder
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75231
- Rekruttering
- Phoenix Thera-Lase Systems
-
Kontakt:
- Paul F White, PhD, MD
- Telefonnummer: 214-770-3775
- E-mail: paul.white@cshs.org
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or female patients
- 25-65 years of age
- taking oral opiate-containing analgesic medication on a PRN
- patient with chronic pain related to an accident, injury or major surgery occurring within the past three years
- Patients with a potentially treatable pain condition
- Patient wiling to complete a daily diary for recording their pain score, activity level, quality of sleep and all pain-related medications for the three-week study period
Exclusion Criteria:
- Use of any opioid-containing pain medications for more than three years
- History of alcohol or drug abuse, or drug-seeking behavior
- Previous treatment for drug abuse in detox center or hospital
- Current psychiatric condition which require centrally- active medications
- Current excessive use of alcohol
- Any unstable medical conditions (e.g. coronary artery disease, hepato-renal or pulmonary disease)
- Patients not capable of consenting for themselves
- Pregnant women
- Women of child bearing potential not using acceptable birth control methods.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Faktoriel opgave
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Low level 1 Watt
The Phoenix Thera-Lase System will be on 1 watt while retaining appropriate "blinding" of both the operator and the patient. Treatments will be applied to the primary area of the body associated with pain for which analgesic (pain) medication is currently required. Each treatment session will last for 20-40 minutes. |
The Phoenix Thera-Lase System will be on 1 watt
Andre navne:
|
Eksperimentel: Phoenix Thera-Lase System 42
The Phoenix Thera-Lase System will be on 42 watts while retaining appropriate "blinding" of both the operator and the patient. Treatments will be applied to the primary area of the body associated with pain for which analgesic (pain) medication is currently required. Each treatment session will last for 20-40 minutes. |
The Phoenix Thera-Lase System will be on 42 watts
Andre navne:
|
Eksperimentel: Phoenix Thera-Lase System 74
The Phoenix Thera-Lase System will be on 74 watts while retaining appropriate "blinding" of both the operator and the patient. Treatments will be applied to the primary area of the body associated with pain for which analgesic (pain) medication is currently required. Each treatment session will last for 20-40 minutes. |
The Phoenix Thera-Lase System will be on 74 watts
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Reduce chronic pain
Tidsramme: 1 month
|
1 month
|
reduce of opioid analgesic dosage.
Tidsramme: one month
|
one month
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Level of physical activity
Tidsramme: 1 month
|
It will be assessed with a questionnaire
|
1 month
|
Quality of sleep
Tidsramme: one month
|
It will be assessed with a questionnaire
|
one month
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Paul F White, PhD, MD, Phoenix Thera-Lase Systems
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 20162211
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Smerte
-
Quiropraxia y EquilibrioUniversidad Nacional Andres BelloAfsluttetMyofascial Trigger Point Pain (MTrP)Chile
-
East Carolina UniversityTrukket tilbage
-
Quiropraxia y EquilibrioIkke rekrutterer endnuMyofascial Trigger Point Pain (MTrP)Chile
-
Wake Forest University Health SciencesRekruttering
-
Rijnstate HospitalSaluda Medical Pty LtdTilmelding efter invitationPolyneuropatier | Kronisk smertesyndrom | Multi Focal Pain | Mislykket nakkekirurgi syndromHolland
-
University of California, San DiegoJohns Hopkins University; United States Department of Defense; The Cleveland... og andre samarbejdspartnereTilmelding efter invitationKirurgisk amputation af nedre ekstremiteter | Post-amputation Phantom Limb PainForenede Stater
-
Oslo University HospitalUniversity of Oslo; Fysiofondet; Oslo Metropolitan UniversityRekrutteringGluteal tendinopati | Trochanterisk bursitis | Lateral hoftesmerter | GTPS - Greater Trochanteric Pain SyndromeNorge
-
Brugmann University HospitalTrukket tilbagePhantom Limb Pain (PLP) | Primær/sekundær arhyperalgesiBelgien
-
Pôle Saint HélierRekruttering
-
Guna S.p.aAfsluttetStørre trochanterisk smertesyndrom | Pertrokantær fraktur | Gluteal tendinitis | GTPS - Greater Trochanteric Pain Syndrome | Senelidelse | Gluteal musklerItalien
Kliniske forsøg med Low level 1 Watt
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloAfsluttetMuskel; Træthed, hjerte | Gendannelse af skeletmusklerBrasilien
-
Shanghai Eye Disease Prevention and Treatment CenterAfsluttet
-
Yolo Medical Inc.Afsluttet
-
Nantes University HospitalAfsluttetKlasse II hund | Intermaxillær styrke | Elastik II | Multi Fasteners ortodontisk behandlingFrankrig
-
Federal University of Rio Grande do SulAfsluttet
-
University of Sao PauloUkendtPulpitis - irreversibelBrasilien
-
Heath SkinnerAfsluttetStrålingsdermatitisForenede Stater
-
Karadeniz Technical UniversityAfsluttet
-
Legacy Health SystemAfsluttetPerifer neuropatiForenede Stater
-
Federal University of Health Science of Porto AlegreUkendt